133 related articles for article (PubMed ID: 37410578)
1. Differentiating Charcot-Marie-Tooth disease from chronic inflammatory demyelinating polyradiculoneuropathy: neurophysiology is not the only clue.
Sommer C
Eur J Neurol; 2023 Dec; 30(12):3642. PubMed ID: 37410578
[No Abstract] [Full Text] [Related]
2. Usefulness of the modified F-ratio for assessments of proximal conduction in chronic inflammatory demyelinating polyneuropathy superimposed on Charcot Marie-Tooth disease type 1A.
Kume K; Deguchi K; Ikeda K; Takata T; Kokudo Y; Kamada M; Tsukaguchi M; Touge T; Masaki T
J Neurol Sci; 2014 Aug; 343(1-2):237-9. PubMed ID: 24906712
[No Abstract] [Full Text] [Related]
3. Electrodiagnosis of demyelinating neuropathies.
Van den Bergh PY; Jacquerye P; Piéret F
Acta Neurol Belg; 2000 Sep; 100(3):188-95. PubMed ID: 11098293
[TBL] [Abstract][Full Text] [Related]
4. CMTX mimicking childhood chronic inflammatory demyelinating neuropathy with tremor.
Ryan MM; Jones HR
Muscle Nerve; 2005 Apr; 31(4):528-30. PubMed ID: 15704145
[No Abstract] [Full Text] [Related]
5. [Charcot-Marie-Tooth disease type 2 caused by homozygous MME gene mutation superimposed by chronic inflammatory demyelinating polyneuropathy].
Fujisawa M; Sano Y; Omoto M; Ogasawara JI; Koga M; Takashima H; Kanda T
Rinsho Shinkeigaku; 2017 Sep; 57(9):515-520. PubMed ID: 28855494
[TBL] [Abstract][Full Text] [Related]
6. [A genetically confirmed CMT1A mimicking relapsing CIDP].
Ben Youssef-Turki I; Kraoua I; Gargouri A; Bouche P; Leguern E; Gouider-Khouja N
Rev Neurol (Paris); 2011 Dec; 167(12):958-9. PubMed ID: 22056228
[No Abstract] [Full Text] [Related]
7. Subacute inflammatory demyelinating polyneuropathy disclosed by massive nerve root enhancement in CMT1A.
Mazzeo A; Stancanelli C; Russo M; Granata F; Gentile L; Di Leo R; Vita G; Nobile-Orazio E; Toscano A
Muscle Nerve; 2012 Mar; 45(3):451-2. PubMed ID: 22173780
[No Abstract] [Full Text] [Related]
8. [Autopsy case of a patient with Charcot-Marie-Tooth disease type 1A and suspected chronic inflammatory demyelinating polyradiculoneuropathy, which was later diagnosed as amyotrophic lateral sclerosis].
Higuchi Y; Sakiyama Y; Nishihira Y; Endo K; Suwazono S; Suehara M
Rinsho Shinkeigaku; 2012; 52(10):750-6. PubMed ID: 23064625
[TBL] [Abstract][Full Text] [Related]
9. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.
Saporta MA; Katona I; Lewis RA; Masse S; Shy ME; Li J
Brain; 2009 Dec; 132(Pt 12):3263-73. PubMed ID: 19923170
[TBL] [Abstract][Full Text] [Related]
10. Charcot-Marie-Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study.
Hauw F; Fargeot G; Adams D; Attarian S; Cauquil C; Chanson JB; Créange A; Gendre T; Deiva K; Delmont E; Francou B; Genestet S; Kuntzer T; Latour P; Le Masson G; Magy L; Nardin C; Ochsner F; Sole G; Stojkovic T; Maisonobe T; Tard C; Van den Berghe P; Echaniz-Laguna A
Eur J Neurol; 2021 Sep; 28(9):2846-2854. PubMed ID: 34060689
[TBL] [Abstract][Full Text] [Related]
11. Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy.
Cottenie E; Menezes MP; Rossor AM; Morrow JM; Yousry TA; Dick DJ; Anderson JR; Jaunmuktane Z; Brandner S; Blake JC; Houlden H; Reilly MM
Neuromuscul Disord; 2013 May; 23(5):399-403. PubMed ID: 23489662
[TBL] [Abstract][Full Text] [Related]
12. Characterization of genetically defined types of Charcot-Marie-Tooth neuropathies by using magnetic resonance neurography.
Ellegala DB; Monteith SJ; Haynor D; Bird TD; Goodkin R; Kliot M
J Neurosurg; 2005 Feb; 102(2):242-5. PubMed ID: 15739551
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of Charcot-Marie-Tooth disease and related neuropathies.
Pareyson D
Neurol Sci; 2004 Jun; 25(2):72-82. PubMed ID: 15221625
[TBL] [Abstract][Full Text] [Related]
14. Are electrophysiological criteria useful in distinguishing childhood demyelinating neuropathies?
Potulska-Chromik A; Ryniewicz B; Aragon-Gawinska K; Kabzinska D; Seroka A; Lipowska M; Kaminska AM; Kostera-Pruszczyk A
J Peripher Nerv Syst; 2016 Mar; 21(1):22-6. PubMed ID: 26663344
[TBL] [Abstract][Full Text] [Related]
15. Electrodiagnostic studies in a murine model of demyelinating Charcot-Marie-Tooth disease.
Meekins GD; Weiss MD
Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):967-79, ix. PubMed ID: 16214054
[No Abstract] [Full Text] [Related]
16. Biomarkers of CIDP in patients with diabetes or CMT1.
Latov N
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():14-7. PubMed ID: 21696491
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory pathological changes in a 2-year-old boy with Charcot-Marie-Tooth disease.
Nakai Y; Okumura A; Takada H; Negoro T; Watanabe K; Hattori N; Sobue G
Brain Dev; 2001 Jul; 23(4):258-60. PubMed ID: 11377008
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy.
Sugimoto T; Ochi K; Hosomi N; Takahashi T; Ueno H; Nakamura T; Nagano Y; Maruyama H; Kohriyama T; Matsumoto M
J Neurol; 2013 Oct; 260(10):2580-7. PubMed ID: 23821028
[TBL] [Abstract][Full Text] [Related]
19. Reversible inflammatory neuropathy superimposed on Charcot-Marie-Tooth type 1A disease.
Gazulla J; Almárcegui C; Berciano J
Neurol Sci; 2018 Apr; 39(4):793-794. PubMed ID: 29164357
[No Abstract] [Full Text] [Related]
20. Compound muscle action potential duration ratio for differentiation between Charcot-Marie-Tooth disease and CIDP.
Kitaoji T; Noto YI; Kojima Y; Tsuji Y; Kitani-Morii F; Mizuno T; Nakagawa M
Clin Neurophysiol; 2023 Feb; 146():124-130. PubMed ID: 36608530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
